title: Cardiac resynchronisation therapy with an implantable cardioverter defibrillator appears to be cost-effective in patients with mild heart failure.
authors.affiliation: University of Southampton, Southampton, UK.
authors.forename: Keith
authors.initials: K
authors.lastname: Cooper
mesh_terms: D058406:Cardiac Resynchronization Therapy; D003362:Cost-Benefit Analysis; D017147:Defibrillators, Implantable; D006333:Heart Failure / Q000628:therapy; D006801:Humans
keywords: HEALTH ECONOMICS